Back

Prognostic importance of persistent elevations in high-sensitivity troponin T in the early convalescent phase (two weeks) following high-risk myocardial infarction: insights from the PARADISE-MI trial

2 September 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Diagnostic and prognostic performance of cardiac troponin Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Karola Jering

Brigham and Women's Hospital, Boston (United States of America)

8 More presentations in this session

Presentation thumbnail
Troponin T as a risk marker for recurrent cardiovascular events in the post-discharge setting one month after acute coronary syndrome: a TRACER substudy
Doctor C. Wassberg (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
High-sensitivity troponin T and risk of stroke in persons with suspected acute coronary syndrome
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Performance of a 99th percentile multiplier troponin score to predict in-hospital events and 1 year mortality in acute coronary syndrome
Slides Video
Presentation thumbnail
Troponin elevation during infection is associated with increased acute and long-term mortality
Slides Video
Presentation thumbnail
Fastidious adherence to 0/1-hour high-sensitivity troponin T testing reduces emergency department length of stay in patients presenting with suspected acute coronary syndromes.
Miss G. Vimalaratnam (AU)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnostic and prognostic performance of cardiac troponin

The Event

Event poster

ESC Congress 2024

2 September 2024 13:00 CET
You may be interested in
thumbnail
Congress Session
High-sensitivity cardiac troponin assays: integrating evidence from clinical trials and implementation studies
thumbnail
Congress Session
Novel biomarkers in acute and chronic coronary syndromes
thumbnail
Congress Presentation
Practical considerations when implementing high-sensitivity troponins: how to advance cardiovascular risk stratification

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources